Nuclear translocation of glutathione transferase omega is a progression marker in Barrett's esophagus
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Nuclear translocation of glutathione transferase omega is a progression marker in Barrett's esophagus. / Piaggi, Simona; Marchi, Santino; Ciancia, Eugenio; Debortoli, Nicola; Lazzarotti, Alessandra; Saviozzi, Michela; Raggi, Chiara; Fierabracci, Vanna; Visvikis, Athanase; Bisgaard, Hanne C; Casini, Alessandro F; Paolicchi, Aldo.
In: Oncology Reports, Vol. 21, No. 2, 2009, p. 283-7.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Nuclear translocation of glutathione transferase omega is a progression marker in Barrett's esophagus
AU - Piaggi, Simona
AU - Marchi, Santino
AU - Ciancia, Eugenio
AU - Debortoli, Nicola
AU - Lazzarotti, Alessandra
AU - Saviozzi, Michela
AU - Raggi, Chiara
AU - Fierabracci, Vanna
AU - Visvikis, Athanase
AU - Bisgaard, Hanne C
AU - Casini, Alessandro F
AU - Paolicchi, Aldo
N1 - Keywords: Barrett Esophagus; Blotting, Western; Cell Nucleus; Disease Progression; Esophageal Neoplasms; Female; Fluorescent Antibody Technique; Glutathione Transferase; Hela Cells; Humans; Immunohistochemistry; Male; Middle Aged; Precancerous Conditions; Protein Transport; Tumor Markers, Biological
PY - 2009
Y1 - 2009
N2 - Barrett's esophagus (BE) represents a major risk factor for esophageal adenocarcinoma (AC). For this reason, patients with BE are subjected to a systematic endoscopic surveillance to detect initial evolution towards non-invasive neoplasia (NiN) and cancer, that eventually occurs only in a small fraction of BE patients. This study was aimed to investigate the possible role of glutathione-S-transferase-omega 1 (GSTO1), a recently discovered member of the glutathione-S-transferase family, as a progression marker in the Barrett's disease in order to improve the diagnosis of NiN in BE and to understand the mechanisms of the progression from BE to AC. We investigated the expression and subcellular localization of GSTO1 in biopsies from patients with BE and in human cancer cell lines subjected to heath shock treatment. A selective nuclear localisation of GSTO1 was found in 16/16 biopsies with low- or high-grade NiN, while it appeared in only 4/22 BE biopsies without signs of NiN (P<0.0001). Among biopsies of BE without NiN, diffuse (nuclear and cytoplasmic) staining was found in 5/22 cases, while selective cytoplasmic localisation was found in 13/22. The 6 cases with indefinite grade of NiN were equally divided between nuclear, cytoplasmic and diffuse staining (2 each, respectively). Experiments in vitro showed that in human HeLa cancer cells, GSTO1 translocates into the nucleus as a consequence of heath shock. These findings suggested that the nuclear translocation of glutathione-S-transferase-omega 1 could be involved in the stress response of human cells playing a role in the cancer progression of Barrett's esophagus. Its immunohistochemical detection could represent a useful tool in the grading of Barrett's disease.
AB - Barrett's esophagus (BE) represents a major risk factor for esophageal adenocarcinoma (AC). For this reason, patients with BE are subjected to a systematic endoscopic surveillance to detect initial evolution towards non-invasive neoplasia (NiN) and cancer, that eventually occurs only in a small fraction of BE patients. This study was aimed to investigate the possible role of glutathione-S-transferase-omega 1 (GSTO1), a recently discovered member of the glutathione-S-transferase family, as a progression marker in the Barrett's disease in order to improve the diagnosis of NiN in BE and to understand the mechanisms of the progression from BE to AC. We investigated the expression and subcellular localization of GSTO1 in biopsies from patients with BE and in human cancer cell lines subjected to heath shock treatment. A selective nuclear localisation of GSTO1 was found in 16/16 biopsies with low- or high-grade NiN, while it appeared in only 4/22 BE biopsies without signs of NiN (P<0.0001). Among biopsies of BE without NiN, diffuse (nuclear and cytoplasmic) staining was found in 5/22 cases, while selective cytoplasmic localisation was found in 13/22. The 6 cases with indefinite grade of NiN were equally divided between nuclear, cytoplasmic and diffuse staining (2 each, respectively). Experiments in vitro showed that in human HeLa cancer cells, GSTO1 translocates into the nucleus as a consequence of heath shock. These findings suggested that the nuclear translocation of glutathione-S-transferase-omega 1 could be involved in the stress response of human cells playing a role in the cancer progression of Barrett's esophagus. Its immunohistochemical detection could represent a useful tool in the grading of Barrett's disease.
M3 - Journal article
C2 - 19148497
VL - 21
SP - 283
EP - 287
JO - Oncology Reports
JF - Oncology Reports
SN - 1021-335X
IS - 2
ER -
ID: 21013239